Evidence map›Paper›PMID 34570959›Full record

ArticleMicrobial biotechnology2022

Genomic insights on fighting bacterial wilt by a novel Bacillus amyloliquefaciens strain Cas02.

Depeng Chu, Naila Ilyas, Lijuan Peng, Xiaoqiang Wang, Dongkun Wang, Zongchang Xu, Qiang Gao, Xiaolei Tan, Chengsheng Zhang, Yiqiang Li and 1 more

Open access · goldAbstract read
In one paragraph

Article in Microbial biotechnology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
4.4field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 27 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Chitooligosaccharide enhanced the efficacy ofFrontiers in microbiology · 2023
    Article
  8. Article
  9. Biocontrol activity and action mechanism ofFrontiers in microbiology · 2022
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 3 institutions in 1 country.

Depeng ChuTobacco Research Institute of Chinese Academy of Agricultural Sciences, Qingdao, 266101, China.
Naila IlyasTobacco Research Institute of Chinese Academy of Agricultural Sciences, Qingdao, 266101, China.
Lijuan PengYunnan Tobacco Quality Supervision and Test Station, Kunming, 650106, China.
Xiaoqiang WangTobacco Research Institute of Chinese Academy of Agricultural Sciences, Qingdao, 266101, China.
Dongkun WangTobacco Research Institute of Chinese Academy of Agricultural Sciences, Qingdao, 266101, China.
Zongchang XuTobacco Research Institute of Chinese Academy of Agricultural Sciences, Qingdao, 266101, China.
Qiang GaoYishui Agricultural Technology Demonstration Park, Linyi, 276400, China.
Xiaolei TanYishui Agricultural Technology Demonstration Park, Linyi, 276400, China.
Chengsheng ZhangTobacco Research Institute of Chinese Academy of Agricultural Sciences, Qingdao, 266101, China.
Yiqiang LiTobacco Research Institute of Chinese Academy of Agricultural Sciences, Qingdao, 266101, China.
Yuan YuanTobacco Research Institute of Chinese Academy of Agricultural Sciences, Qingdao, 266101, China.ORCID 0000-0002-2689-102X
Tobacco Research Institute · CNLinyi University · CNChina Tobacco · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Bacterial wilt, caused by the Ralstonia solanacearum, can infect several economically important crops. However, the management strategies available to control this disease are limited. Plant growth-promoting rhizobacteria (PGPR) have been considered promising biocontrol agents. In this study, Bacillus amyloliquefaciens strain Cas02 was isolated from the rhizosphere soil of healthy tobacco plants and evaluated for its effect on plant growth promotion and bacterial wilt suppression. Strain Cas02 exhibited several growth-promoting-related features including siderophore production, cellulase activity, protease activity, ammonia production and catalase activity. Moreover, strain Cas02 showed a significant inhibitory growth effect on R. solanacearum, and its active substances were separated and identified to be macrolactin A and macrolactin W by HPLC-DAD-ESI-MS/MS. Both greenhouse and field experiments demonstrated a good performance of Cas02 in plant growth promotion and bacterial wilt suppression. To explore the underlying genetic mechanisms, complete genome sequencing was performed and the gene clusters responsible for antibacterial metabolites expression were identified. Overall, these findings suggest that the strain Cas02 could be a potential biocontrol agent in bacterial wilt management and a source of antimicrobial compounds for further exploitation.

Indexed as

Bacillus amyloliquefaciensRalstonia solanacearumSolanum lycopersicumPlant DiseasesTandem Mass Spectrometry

Identifiers

PMID34570959
PMCPMC8966013
OpenAlexW3204968051

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.